Bioinformatics Advance Access originally published online on September 10, 2009
Bioinformatics 2009 25(22):2891-2896; doi:10.1093/bioinformatics/btp538
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Phenotypic categorization of genetic skin diseases reveals new relations between phenotypes, genes and pathways
1Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-9050, 2Department of Dermatology, University of California at San Francisco, San Francisco, CA 94115, 3Wellman Center for Photomedicine, Department of Dermatology, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114, and 4Department of Biochemistry, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-9050, USA
*To whom correspondence should be addressed.
| Abstract |
|---|
Motivation: Systematic analysis of connection between proteins, their cellular function and phenotypic manifestations in disease is a central problem of biological and clinical research. The solution to this problem requires the development of new approaches to link the rapidly growing dataset of gene–disease associations with the many complex and overlapping phenotypes of human disease.
Results: We analyze genetic skin disorders and suggest a manually designed set of elementary phenotypes whose combinations define diseases as points in a multidimensional space, providing a basis for phenotypic disease clustering. Placing the known gene–disease associations in the context of this space reveals new patterns that suggest previously unknown functional links between proteins, signaling pathways and disease phenotypes. For example, analysis of telangiectasias (spider vein diseases) reveals a previously unrecognized interplay between the TGF-β signaling pathway and pentose phosphate pathway. This interaction may mediate glucose-dependent regulation of TGF-β signaling, providing a clue to the known association between angiopathies and diabetes and implying new gene candidates for mutational analysis and drug targeting.
Contact: grishin{at}chop.swmed.edu
Supplementary information: Supplementary data are available at Bioinformatics online.
Associate Editor: Jonathan Wren
Received on May 11, 2009; revised on August 10, 2009; accepted on September 7, 2009